Allscripts Healthcare Solutions - MDRX Stock Forecast, Price & News

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Allscripts Healthcare Solutions Trading Down 0.5 %

NASDAQ:MDRX opened at $17.45 on Tuesday. Allscripts Healthcare Solutions has a 1 year low of $13.05 and a 1 year high of $23.25. The company has a debt-to-equity ratio of 0.17, a quick ratio of 2.38 and a current ratio of 3.23. The stock has a market cap of $2.02 billion, a P/E ratio of 40.58, a P/E/G ratio of 1.60 and a beta of 1.02. The stock has a 50-day simple moving average of $15.58 and a 200-day simple moving average of $18.83.

Allscripts Healthcare Solutions (NASDAQ:MDRX - Get Rating) last posted its earnings results on Thursday, August 4th. The software maker reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.03. Allscripts Healthcare Solutions had a return on equity of 10.62% and a net margin of 5.90%. The business had revenue of $150.90 million during the quarter, compared to the consensus estimate of $148.58 million. During the same period in the previous year, the business earned $0.17 EPS. The business's quarterly revenue was up 6.9% on a year-over-year basis. As a group, analysts anticipate that Allscripts Healthcare Solutions will post 0.67 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. TheStreet downgraded Allscripts Healthcare Solutions from a "b" rating to a "c" rating in a research report on Friday, May 6th. Piper Sandler dropped their price objective on Allscripts Healthcare Solutions from $19.00 to $17.00 in a research note on Thursday, June 9th. StockNews.com cut Allscripts Healthcare Solutions from a "buy" rating to a "hold" rating in a research note on Friday, May 13th. Finally, The Goldman Sachs Group initiated coverage on Allscripts Healthcare Solutions in a research note on Tuesday, July 12th. They issued a "neutral" rating and a $21.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $21.80.

Insider Activity

In other Allscripts Healthcare Solutions news, Director Paul Black sold 60,000 shares of the company's stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $16.58, for a total transaction of $994,800.00. Following the completion of the sale, the director now directly owns 1,254,631 shares of the company's stock, valued at approximately $20,801,781.98. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Allscripts Healthcare Solutions news, Director Paul Black sold 60,000 shares of the company's stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $16.58, for a total transaction of $994,800.00. Following the completion of the sale, the director now directly owns 1,254,631 shares of the company's stock, valued at approximately $20,801,781.98. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Elizabeth Ann Altman sold 6,028 shares of the company's stock in a transaction that occurred on Friday, May 27th. The shares were sold at an average price of $16.75, for a total value of $100,969.00. Following the sale, the director now directly owns 22,796 shares of the company's stock, valued at $381,833. The disclosure for this sale can be found here. In the last three months, insiders sold 266,478 shares of company stock valued at $4,616,204. Insiders own 2.29% of the company's stock.